Dermapharm Holding SE
DMPHFOTCHealthcare● Active
$59.00
+$19.44(+49.14%)
Market Cap$2.9B
P/E Ratio—
52W High$59
52W Low$39.56
Dermapharm Holding SE (DMPHF) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · DMPHF · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $0.13B | $0.17B | $0.06B | $0.22B | $0.29B |
| Depreciation & Amort. | $0.09B | $0.09B | $0.10B | $0.09B | $0.06B |
| Stock-Based Comp. | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Change in Working Capital | $0.00B | ($0.02B) | $0.01B | ($0.00B) | ($0.05B) |
| Net Cash from Operations | $0.18B | $0.20B | $0.22B | $0.29B | $0.25B |
| Investing Activities | |||||
| Capital Expenditure | ($0.04B) | ($0.04B) | ($0.04B) | ($0.04B) | ($0.06B) |
| Purchases of Investments | ($0.01B) | ($0.00B) | $0.00B | ($0.01B) | ($0.05B) |
| Sales of Investments | $0.00B | $0.00B | $0.01B | $0.01B | $0.06B |
| Net Cash from Investing | ($0.11B) | ($0.03B) | ($0.42B) | ($0.10B) | ($0.13B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Dividends Paid | ($0.05B) | ($0.05B) | ($0.06B) | ($0.12B) | ($0.05B) |
| Debt Issued / Repaid | $0.07B | ($0.10B) | $0.30B | ($0.07B) | ($0.03B) |
| Net Cash from Financing | $0.01B | ($0.21B) | $0.20B | ($0.20B) | ($0.08B) |
| Free Cash Flow | |||||
| Free Cash Flow | $0.14B | $0.16B | $0.18B | $0.25B | $0.19B |
| FCF Margin %(computed) | 11.97% | 13.82% | 15.46% | 24.35% | 20.06% |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · EUR · B
Explore more Dermapharm Holding SE data
About Dermapharm Holding SE (DMPHF) Cash Flow Statement
Dermapharm Holding SE generated operating cash flow of $0.18B and free cash flow of $0.14B for 2025 — a FCF margin of 11.97%. Capital expenditure was ($0.04B).
Frequently asked questions
DMPHF · 4 questionsDermapharm Holding SE generated free cash flow of $0.14B for 2025, down 14.6% year-over-year.
DMPHF free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10